Mariner
ACH

Mariner’s Accendra Health ACH Stock Holding History

Mariner’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311K Buy
90,822
+77,038
+559% +$239K ﹤0.01% 2819
2026
Q1 		$31.4K Buy
+13,784
New +$31.7K ﹤0.01% 3465
2025
Q3 		– Sell
-23,266
Closed -$212K – 3704
2025
Q2 		$212K Sell
23,266
-7,264
-24% -$53.5K ﹤0.01% 3005
2025
Q1 		$276K Buy
30,530
+19,284
+171% +$204K ﹤0.01% 2706
2024
Q4 		$147K Sell
11,246
-7,493
-40% -$99.9K ﹤0.01% 3098
2024
Q3 		$295K Buy
18,739
+2,573
+16% +$39K ﹤0.01% 2584
2024
Q2 		$218K Sell
16,166
-6,520
-29% -$134K ﹤0.01% 2723
2024
Q1 		$629K Buy
22,686
+3,671
+19% +$81.5K ﹤0.01% 1859
2023
Q4 		$366K Sell
19,015
-1,661
-8% -$30.1K ﹤0.01% 2173
2023
Q3 		$334K Buy
20,676
+4,718
+30% +$83.7K ﹤0.01% 2064
2023
Q2 		$304K Buy
15,958
+4,277
+37% +$76.3K ﹤0.01% 2111
2023
Q1 		$170K Sell
11,681
-1,021
-8% -$18.3K ﹤0.01% 2455
2022
Q4 		$248K Buy
+12,702
New +$248K ﹤0.01% 2183

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mariner's ACH Position: Q2 2026 in Review

Mariner increased its Accendra Health (ACH) stake by 559% in Q2 2026, buying an estimated $239K and bringing the position to 90,822 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #2819.

Mariner first reported a position in ACH in Q4 2022 and has held it in 13 quarters since. The position peaked at $629K in Q1 2024. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Mariner held 90,822 shares of Accendra Health worth $311K as of Q2 2026.
  • Mariner bought 77,038 Accendra Health shares in Q2 2026, an estimated $239K.
  • Accendra Health made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2819 holding.
  • Mariner first reported a position in Accendra Health in Q4 2022 and has held it in 13 quarters since.
  • Mariner's Accendra Health position peaked at $629K in Q1 2024.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.